Updated Sep 24, 2026
Neuralink
Neuralink conducts an investigational first-in-human brain-computer-interface study to evaluate safety and initial effectiveness before sale. Its patient registries provide consent-based participation and allow withdrawal with deletion of registry records.
Concord Index
Insufficient public record
The public record supports 1 of dimensions. Naming a model takes at least six, so this report shows the evidence without a match.
Evidence summary.
Each verified dimension starts with the company position and its citations. Open a dimension only when you want the underlying questions or model answers.
Distribution
Market allocation ↔ Redistribution
Not verified
No company position
No documented compensation, ownership, or pay-equity practice.
Purpose
Shareholder returns ↔ Stakeholder welfare
Not verified
No company position
No company-wide commercial or stakeholder decision rule is established.
Worker voice
Management discretion ↔ Employee influence
Not verified
No company position
No evidence concerns Neuralink's own workforce voice or working-condition authority.
Equality
Uniform treatment ↔ Targeted measures
Not verified
No company position
Study eligibility criteria do not establish employment standards.
Speech
Broad expression ↔ Protective moderation
Not verified
No company position
No workplace-expression or platform-content policy is documented.
Privacy
Individual privacy ↔ Collective oversight
25%
Company position toward collective oversight
The UK registry commits to ending further collection and use following withdrawal and permanently deleting registry records within one month.
“Upon receiving your withdrawal request, Neuralink will stop any further use and collection of your personal information as soon as reasonably possible, and will permanently delete your records from the Patient Registry UK within one (1) month of receipt of such request.”
Patient-Registry-Consent-Form-UK.pdf
Regulation
Voluntary standards ↔ Public regulation
Not verified
No company position
IRB review does not establish adoption of a voluntary standard or advocacy for binding public rules.
Global outlook
Local priority ↔ International openness
Not verified
No company position
The verified quotation does not contain the wording its evidence anchor requires.
“PATIENT REGISTRY: CANADA INFORMED CONSENT FORM”
Patient-Registry-Consent-Form-Canada.pdf
“PATIENT REGISTRY UK: CONSENT FORM”
Patient-Registry-Consent-Form-UK.pdf
Social change
Continuity ↔ Experimentation
Not verified
No company position
No documented company-wide pilot, revision, or experimentation operating principle.
Environment
Near-term growth ↔ Ecological restraint
Not verified
No company position
No environmental operating commitment or practice is documented.
Tech pace
Rapid advancement ↔ Precaution
Not verified
No company position
The study evaluates safety, but the supplied excerpts do not establish a required pre-deployment risk-review, testing, or staged-release policy.
AI autonomy
Delegated autonomy ↔ Human authority
Not verified
No company position
No evidence addresses automated consequential decisions or human approval authority.
Protocol values-2026-09-v8. Panel representative-2026-09-v11. Report version 2c6c6be3-9806-47f1-83f2-77649297a5dc.